436 related items for PubMed ID: 31302740
1. A comparison of serum IL6 and CRP levels with respect to coronary changes and treatment response in Kawasaki disease patients: a prospective study.
Nandi A, Pal P, Basu S.
Rheumatol Int; 2019 Oct; 39(10):1797-1801. PubMed ID: 31302740
[Abstract] [Full Text] [Related]
2. Predictors for intravenous immunoglobulin resistance and coronary artery lesions in Kawasaki disease.
Xie T, Wang Y, Fu S, Wang W, Xie C, Zhang Y, Gong F.
Pediatr Rheumatol Online J; 2017 Mar 21; 15(1):17. PubMed ID: 28320400
[Abstract] [Full Text] [Related]
3. Evaluation of intravenous immunoglobulin resistance and coronary artery lesions in relation to Th1/Th2 cytokine profiles in patients with Kawasaki disease.
Wang Y, Wang W, Gong F, Fu S, Zhang Q, Hu J, Qi Y, Xie C, Zhang Y.
Arthritis Rheum; 2013 Mar 21; 65(3):805-14. PubMed ID: 23440694
[Abstract] [Full Text] [Related]
4. Importance of C-reactive protein level in predicting non-response to additional intravenous immunoglobulin treatment in children with Kawasaki disease: a retrospective study.
Iwashima S, Kimura M, Ishikawa T, Ohzeki T.
Clin Drug Investig; 2011 Mar 21; 31(3):191-9. PubMed ID: 21456105
[Abstract] [Full Text] [Related]
5. Predictive Value of Serum Lipid for Intravenous Immunoglobulin Resistance and Coronary Artery Lesion in Kawasaki Disease.
Shao S, Zhou K, Liu X, Liu L, Wu M, Deng Y, Duan H, Li Y, Hua Y, Wang C.
J Clin Endocrinol Metab; 2021 Sep 27; 106(10):e4210-e4220. PubMed ID: 33837779
[Abstract] [Full Text] [Related]
6. Predictive value of monocyte to HDL-C ratio for coronary artery lesions and intravenous immunoglobulin resistance in Kawasaki disease.
Wang JR, Zhao HZ, Chang LJ, Xu X, Gao Y, Li M, Kong QY, Wang MM, Zhao CF.
Eur J Pediatr; 2023 Oct 27; 182(10):4399-4406. PubMed ID: 37480545
[Abstract] [Full Text] [Related]
7. The role of serum lipid in predicting coronary artery lesions and intravenous immunoglobulin resistance in Kawasaki disease: a cohort study.
Zhang H, Cai J, Zhang R, Shuai S, Tang M, Ju R, Hu Y, Zuo T, Yang Y.
J Int Med Res; 2024 May 27; 52(5):3000605241252115. PubMed ID: 38713460
[Abstract] [Full Text] [Related]
8. Delayed intravenous immunoglobulin treatment increased the risk of coronary artery lesions in children with Kawasaki disease at different status.
Qiu H, He Y, Rong X, Ren Y, Pan L, Chu M, Wu R, Shi H.
Postgrad Med; 2018 May 27; 130(4):442-447. PubMed ID: 29745742
[Abstract] [Full Text] [Related]
9. Inflammatory cytokines as predictors of resistance to intravenous immunoglobulin therapy in Kawasaki disease patients.
Sato S, Kawashima H, Kashiwagi Y, Hoshika A.
Int J Rheum Dis; 2013 Apr 27; 16(2):168-72. PubMed ID: 23773640
[Abstract] [Full Text] [Related]
10. Interleukin-6 is prone to be a candidate biomarker for predicting incomplete and IVIG nonresponsive Kawasaki disease rather than coronary artery aneurysm.
Wu Y, Liu FF, Xu Y, Wang JJ, Samadli S, Wu YF, Liu HH, Chen WX, Luo HH, Zhang DD, Wei W, Hu P.
Clin Exp Med; 2019 May 27; 19(2):173-181. PubMed ID: 30617865
[Abstract] [Full Text] [Related]
11. Increased Pentraxin 3 Levels Correlate With IVIG Responsiveness and Coronary Artery Aneurysm Formation in Kawasaki Disease.
Kitoh T, Ohara T, Muto T, Okumura A, Baba R, Koizumi Y, Yamagishi Y, Mikamo H, Daigo K, Hamakubo T.
Front Immunol; 2021 May 27; 12():624802. PubMed ID: 33912155
[Abstract] [Full Text] [Related]
12. Serum IL-41 might be a biomarker for IVIG resistance and coronary artery lesions in Kawasaki disease.
Duan Y, Li H, Luo D, Jiang J, Liu B, Li G.
Int Immunopharmacol; 2023 Sep 27; 122():110600. PubMed ID: 37423157
[Abstract] [Full Text] [Related]
13. A comparative study of IL-6, CRP and NT-proBNP levels in post-COVID multisystem inflammatory syndrome in children (MISC) and Kawasaki disease patients.
Ganguly M, Nandi A, Banerjee P, Gupta P, Sarkar SD, Basu S, Pal P.
Int J Rheum Dis; 2022 Jan 27; 25(1):27-31. PubMed ID: 34750969
[Abstract] [Full Text] [Related]
14. Infliximab Plus Intravenous Immunoglobulin (IVIG) Versus IVIG Alone as Initial Therapy in Children With Kawasaki Disease Presenting With Coronary Artery Lesions: Is Dual Therapy More Effective?
Jone PN, Anderson MS, Mulvahill MJ, Heizer H, Glodé MP, Dominguez SR.
Pediatr Infect Dis J; 2018 Oct 27; 37(10):976-980. PubMed ID: 29461447
[Abstract] [Full Text] [Related]
15. Interleukin-18 and coronary artery lesions in patients with Kawasaki disease.
Weng KP, Hsieh KS, Huang SH, Ou SF, Lai TJ, Tang CW, Lin CC, Ho TY, Liou HH, Ger LP.
J Chin Med Assoc; 2013 Aug 27; 76(8):438-45. PubMed ID: 23769880
[Abstract] [Full Text] [Related]
16. Serum tenascin-C predicts resistance to steroid combination therapy in high-risk Kawasaki disease: a multicenter prospective cohort study.
Yoshikane Y, Okuma Y, Miyamoto T, Hashimoto J, Fukazawa R, Kato T, Takeda A, Suda K, Matsushita T, Hiroe M, Imanaka-Yoshida K.
Pediatr Rheumatol Online J; 2021 Jun 05; 19(1):82. PubMed ID: 34090475
[Abstract] [Full Text] [Related]
17. N-terminal pro-brain natriuretic peptide and risk of coronary artery lesions and resistance to intravenous immunoglobulin in Kawasaki disease.
Yoshimura K, Kimata T, Mine K, Uchiyama T, Tsuji S, Kaneko K.
J Pediatr; 2013 Jun 05; 162(6):1205-9. PubMed ID: 23290510
[Abstract] [Full Text] [Related]
18. Serum amyloid A as a biomarker for immunoglobulin resistance in Kawasaki disease.
Huang XB, Zhao S, Liu ZY, Xu YY, Deng F.
Ann Med; 2023 Jun 05; 55(2):2264315. PubMed ID: 37870383
[Abstract] [Full Text] [Related]
19. Predictive value of albumin for intravenous immunoglobulin resistance in a large cohort of Kawasaki disease patients.
Zhang R, Shuai S, Zhang H, Cai J, Cui N, Tang M, Xing S, Gao Y, Liu X, Yang X.
Ital J Pediatr; 2023 Jun 25; 49(1):78. PubMed ID: 37357258
[Abstract] [Full Text] [Related]
20. Kawasaki disease in Turkish children: a single center experience with emphasis on intravenous immunoglobulin resistance and giant coronary aneurysms.
Yılmazer MM, Özdemir R, Meşe T, Küçük M, Öner T, Devrim İ, Bayram N, Güven B, Tavlı V.
Turk J Pediatr; 2019 Jun 25; 61(5):648-656. PubMed ID: 32104995
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
